Sympathetic nervous system disorder
MONDO:0044993A disease or disorder that involves the sympathetic nervous system.
Also known as: disease of sympathetic nervous system, disease or disorder of sympathetic nervous system, disorder of sympathetic nervous system, sympathetic nervous system disease, sympathetic nervous system disease or disorder
28 clinical trials for this condition and its sub-types, 8 tagged with Sympathetic nervous system disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Sympathetic nervous system disorder
-
Sympathetic paraganglioma 0 trials · 16 incl. sub-types
2 sub-types
- Adrenal gland pheochromocytoma 5 trials · 16 incl. sub-types Sub-types →
- Extra-adrenal sympathetic paraganglioma 0 trials
-
Ganglioneuroma 5 trials
1 sub-type
- Cutaneous ganglioneuroma 0 trials
Most studied deeper sub-types
-
A new imaging tracer may reveal hidden nerve injuries
Diagnosis Recruiting nowThis trial tests whether an injected tracer called HED, seen on PET/CT or MRI scans, can help diagnose diseases of the sympathetic nervous system, the part of the body that controls automatic responses like heart rate and blood pressure. Researchers will scan 500 adults who have …
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Scientists probe hidden nerve signals in COPD patients
Knowledge-focused Recruiting nowThis study looks at why people with COPD may have overactive nerve signals that increase heart rate and narrow blood vessels. Researchers will measure nerve activity, breathing, and inflammation in 135 adults with COPD. The goal is to better understand the causes, not to test a n…
Sponsor: RWTH Aachen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Aging Women's blood flow secrets revealed in new study
Knowledge-focused Recruiting nowThis study looks at how blood flow and the nervous system adapt early in aging women. Researchers will measure forearm blood flow in 64 women aged 18-70. The goal is to better understand these changes, not to test a treatment.
Early phase 1 • Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC